SCHEMBL1664150

SCHEMBL1664150

N#Cc1cc(Nc2ccc(N3CCC(C(F)(F)F)CC3)cc2)ccc1Nc1ccc(NC(=O)c2cc[nH]c2)cc1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 5/20 0.41
ALDH1A1 P00352 3/20 0.41
MAPT P10636 3/20 0.41
MEN1 O00255 2/20 0.41
KMT2A Q03164 2/20 0.41
NPSR1 Q6W5P4 2/20 0.41
RXFP1 Q9HBX9 2/20 0.41
HPGD P15428 1/20 0.41
HSD17B10 Q99714 1/20 0.41
TBK1 Q9UHD2 4/20 0.38
JAK2 O60674 3/20 0.38
ABL1 P00519 5/20 0.37
NPC1 O15118 6/20 0.37
RAB9A P51151 6/20 0.37
EGFR P00533 2/20 0.36
TP53 P04637 2/20 0.36
TSHR P16473 1/20 0.36
USP2 O75604 1/20 0.35
ALOX15 P16050 1/20 0.35
MAPK1 P28482 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1664151 0.96 KMT2A (0.46) SMN1; SMN2ALDH1A1MAPTMEN1KMT2A
SCHEMBL1664932 0.90 ALDH1A1 (0.42) SMN1; SMN2ALDH1A1MAPTMEN1KMT2A
SCHEMBL1664139 0.89 ALDH1A1 (0.44) SMN1; SMN2ALDH1A1MAPTMEN1KMT2A
SCHEMBL1664141 0.86 KMT2A (0.48) SMN1; SMN2ALDH1A1MAPTMEN1KMT2A
SCHEMBL1664935 0.86 KMT2A (0.48) SMN1; SMN2ALDH1A1MAPTMEN1KMT2A
SCHEMBL21254498 0.84 KMT2A (0.48) SMN1; SMN2ALDH1A1MAPTMEN1KMT2A
SCHEMBL24865620 0.78 DRD2 (0.38) SMN1; SMN2ALDH1A1MAPTMEN1KMT2A
SCHEMBL30336093 0.78 DRD2 (0.38) SMN1; SMN2ALDH1A1MAPTMEN1KMT2A
SCHEMBL1665596 0.78 MAPT (0.54) SMN1; SMN2ALDH1A1MAPTMEN1KMT2A
SCHEMBL1664163 0.77 SMN1; SMN2 (0.44) SMN1; SMN2ALDH1A1MAPTMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2642994-A2 USE OF HEMATOPOIETIC GROWTH FACTOR MIMETICS Ligand Pharmaceuticals Incorporated (US) 2013-10-02 EP disclosed
EP-2488486-A1 HEMATOPOIETIC GROWTH FACTOR MIMETIC SMALL MOLECULE COMPOUNDS AND THEIR USES Ligand Pharmaceuticals Inc. (US) 2012-08-22 EP disclosed
WO-2012068406-A2 USE OF HEMATOPOIETIC GROWTH FACTOR MIMETICS LIGAND PHARMACEUTICALS INCORPORATED (US) 2012-05-24 WO disclosed
WO-2011046954-A1 HEMATOPOIETIC GROWTH FACTOR MIMETIC SMALL MOLECULE COMPOUNDS AND THEIR USES LIGAND PHARMACEUTICALS INC. (US) 2011-04-21 WO disclosed